Compare · MCK vs NUS
MCK vs NUS
Side-by-side comparison of McKesson Corporation (MCK) and Nu Skin Enterprises Inc. (NUS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MCK and NUS operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- MCK is the larger of the two at $105.52B, about 447.0x NUS ($236.1M).
- MCK has been more active in the news (8 items in the past 4 weeks vs 5 for NUS).
- MCK has more recent analyst coverage (25 ratings vs 4 for NUS).
- Company
- McKesson Corporation
- Nu Skin Enterprises Inc.
- Price
- -
- -
- Market cap
- $105.52B
- $236.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NYSE
- IPO
- 1996
- News (4w)
- 8
- 5
- Recent ratings
- 25
- 4
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Nu Skin Enterprises Inc.
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Latest MCK
- McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
- RBC Capital Mkts initiated coverage on McKesson with a new price target
- SEC Form 4 filed by EVP and Chief Strategy Officer Srinivasan Ramesh (Nmn)
- Director Lerman Bradley E sold $268,590 worth of shares (301 units at $892.33), closing all direct ownership in the company (SEC Form 4)
- New insider Srinivasan Ramesh (Nmn) claimed ownership of 11,959 shares (SEC Form 3)
- SEC Form 10-Q filed by McKesson Corporation
- McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance
- McKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- McKesson Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Director Hinton James H.
Latest NUS
- Nu Skin Enterprises Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by Nu Skin Enterprises Inc.
- Nu Skin Enterprises Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Nu Skin Enterprises Reports Second Quarter Results
- Nu Skin Enterprises Announces Quarterly Dividend
- Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
- Director Winett James M was granted 26,643 shares and sold $40,481 worth of shares (7,203 units at $5.62) as part of a pre-agreed trading plan, increasing direct ownership by 108% to 37,448 units (SEC Form 4)
- Director Nathanson Laura was granted 26,643 shares, increasing direct ownership by 87% to 57,116 units (SEC Form 4)
- Director Zorko Mark A was granted 26,643 shares, increasing direct ownership by 78% to 60,586 units (SEC Form 4)
- Director Woodbury Edwina D was granted 26,643 shares and sold $41,057 worth of shares (7,203 units at $5.70) as part of a pre-agreed trading plan, increasing direct ownership by 45% to 62,433 units (SEC Form 4)